|
(P1430) |
Organferne ischämische Präkonditionierung (RIPC) vor transfemoralem Aortenklappenersatz (TAVI): Eine Option zur Reduktion der peri-interventionellen Myokardschädigung und Verbesserung des Outcomes? |
| |
|
M. Flechsig, W. Tröger, S. Müller, T. Schmidt, J. Nicolai, N. Hartmann, S. Quick, U. Speiser, R. H. Strasser, K. Ibrahim, S. Wiedemann, F. M. Heidrich (Dresden) |
|
(P1431) |
Incidence and impact of neoplasia in patients treated with TAVI for severe aortic valve stenosis |
| |
|
R. Mincu, R. A. Janosi, A. Lind, P. Kahlert, T. Rassaf, M. Totzeck (Essen) |
|
(P1432) |
Risk Factors and Outcome of Postoperative Delirium after Transcatheter Aortic Valve Replacement |
| |
|
P. Stachon, K. Kaier, A. Zirlik, M. Zehender, C. Bode, C. von zur Mühlen (Freiburg im Breisgau, Freiburg) |
|
(P1433) |
A novel In-house Risk Score can Predict enhanced Periprocedural Costs and Length of Stay |
| |
|
F. Häcker, P. Ledwig, G. Papadopoulos, D. Sötemann, O. Maier, T. Zeus, M. Kelm, V. Veulemans (Düsseldorf) |
|
(P1434) |
Increased perinterventional risk for patients with severe aortic stenosis and pulmonary hypertension treated by transfemoral aortic valve implantation |
| |
|
G. Papadopoulos, S. Keymel, J.-P. Minol, A. Blehm, S. Krüger, C. Jung, R. Westenfeld, A. Lichtenberg, M. Kelm, T. Zeus, V. Veulemans (Düsseldorf) |